SUBSCRIBE
SUBSCRIBE
News   Drug Development

US FDA Staff Question Allos Therapeutics, Inc. Lymphoma Drug Data

August 31, 2009 | 
1 min read
Bookmark and Share

Reuters -- U.S. drug reviewers questioned findings from biotech company Allos Therapeutics Inc on the effectiveness of its proposed drug for an aggressive type of lymphoma, documents released on Friday showed.
Clinical research Postmarket research
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Hand holding a lung shape symbol against a blue background. World tuberculosis day, world no tobacco day, lung cancer, pulmonary hypertension, pneumonia
Lung cancer
BMS, BioNTech Post Geographically Consistent Mid-Stage PD-L1/VEGF Data in SCLC
September 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Collage art of a hand touching a cat. Modern and creative design with surreal style. Perfect for use in posters, editorial design, social media, digital art, and contemporary art projects
Allergies
Regeneron’s Antibodies Block Cat and Birch Allergies With ‘Robust Activity’
September 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Modern data center with AI server racks connected by glowing blue lines, representing artificial intelligence, advanced computing, and data processing.
Drug Development
If Data Is the New Oil, AI Is the Refinery
September 8, 2025
 · 
5 min read
 · 
Lori Ellis
Contemporary art collage of woman sitting in the lotus position, cloud, pillows against the background of the night sky. Concept of healthy lifestyle and sport. Good and relaxing sleep. Copy space.
Neuroscience
Alkermes One Ups Takeda in Narcolepsy, Clearing Cognitive Impairments in Mid-Stage Trial
September 8, 2025
 · 
2 min read
 · 
Dan Samorodnitsky